These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14756095)

  • 41. Medicine and industry: a necessary but conflicted relationship.
    Fisher MA
    Perspect Biol Med; 2007; 50(1):1-6. PubMed ID: 17259671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Editorial: limitations of the physicians' desk reference 2007.
    Mindel JS; Teich SA; Teich CM; Beam P
    Surv Ophthalmol; 2008; 53(1):82-4. PubMed ID: 18191659
    [No Abstract]   [Full Text] [Related]  

  • 43. Leading the campaign to reduce conflicts of interest.
    Health Prog; 2009; 90(4):52-3. PubMed ID: 19603720
    [No Abstract]   [Full Text] [Related]  

  • 44. [Physicians and drug industry].
    Hanssen KF
    Tidsskr Nor Laegeforen; 2012 Feb; 132(4):386-7. PubMed ID: 22353819
    [No Abstract]   [Full Text] [Related]  

  • 45. Should a medical practice accept a gift with strings attached?
    Agrawal M; Steinberg D
    Med Ethics (Burlingt Mass); 2001; ():3, 7. PubMed ID: 15584189
    [No Abstract]   [Full Text] [Related]  

  • 46. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members".
    Adler AC
    Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117082
    [No Abstract]   [Full Text] [Related]  

  • 47. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members".
    Coli R
    Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117081
    [No Abstract]   [Full Text] [Related]  

  • 48. How to manage conflicts of interest with industry?
    Schowalter JE
    Int Rev Psychiatry; 2008 Apr; 20(2):127-33. PubMed ID: 18386202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doctors and the drug industry: reader feedback.
    Warrier R; Houghton B
    Am J Med; 2005 Oct; 118(10):1175-6; author reply 1176. PubMed ID: 16194656
    [No Abstract]   [Full Text] [Related]  

  • 50. Pens, trips, and the public trust: support for stronger action.
    Federman DG
    Conn Med; 2006 Aug; 70(7):449-50. PubMed ID: 16937721
    [No Abstract]   [Full Text] [Related]  

  • 51. The pharma industry--redressing the balance.
    Panay N; Fenton A
    Climacteric; 2008 Oct; 11(5):353-4. PubMed ID: 18781478
    [No Abstract]   [Full Text] [Related]  

  • 52. [A group of physicians battling against?].
    Reseland S
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):68. PubMed ID: 15643474
    [No Abstract]   [Full Text] [Related]  

  • 53. [Drug industry and double morals].
    Gradek G
    Tidsskr Nor Laegeforen; 2011 Nov; 131(21):2111. PubMed ID: 22048202
    [No Abstract]   [Full Text] [Related]  

  • 54. [Physicians and drug industry--open cooperation is the way forward].
    Ibsen TB
    Ugeskr Laeger; 2004 Apr; 166(17):1585. PubMed ID: 15146699
    [No Abstract]   [Full Text] [Related]  

  • 55. Gifts from pharmaceutical reps: exercise caution.
    Beatty Y
    Tenn Med; 2005 Jan; 98(1):33-4. PubMed ID: 15696818
    [No Abstract]   [Full Text] [Related]  

  • 56. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Medical doctors and pharmaceutical industry].
    de Francisco AL
    Nefrologia; 2004; 24(5):393-4. PubMed ID: 15648899
    [No Abstract]   [Full Text] [Related]  

  • 58. Debunking myths in physician-industry conflicts of interest.
    Lichter PR
    Am J Ophthalmol; 2008 Aug; 146(2):159-71. PubMed ID: 18538299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

  • 60. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.